#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14434	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2157	662.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1440	1440	C	789	C,G	766,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26112	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3673	706.9	0	.	n	.	0	T695C	SNP	695	695	T	1152	1152	C	757	C,T	747,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26112	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3673	706.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1794	1794	A	838	A,G,T	818,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26112	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3673	706.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2428	2428	C	798	C	780	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26112	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3673	706.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3054	3054	T	746	T,C	388,344	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26112	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3673	706.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2502	2502	A	791	A	779	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1974	folP	852	852	100.0	folP.l15.c4.ctg.1	1525	128.4	1	SNP	p	R228S	1	.	.	682	684	AGC	945	947	AGC	175;175;175	A;G;C	173;174;170	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5014	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3358	148.1	1	SNP	p	S91F	0	.	.	271	273	TCC	582	584	TCC	170;171;168	T;C;C	166;170;166	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5014	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3358	148.1	1	SNP	p	D95G	0	.	.	283	285	GAC	594	596	GAC	171;171;172	G;A,C;C	168;163,2;170	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5014	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3358	148.1	1	SNP	p	D95N	0	.	.	283	285	GAC	594	596	GAC	171;171;172	G;A,C;C	168;163,2;170	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1584	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1191	131.3	0	.	p	.	0	F184L	NONSYN	550	552	TTC	823	825	TTG	180;181;178	T;T;G	178;179;174	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1584	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1191	131.3	1	SNP	p	G45D	0	.	.	133	135	GGC	406	408	GGC	182;183;182	G;G;C	180;181;180	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	794	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1081	73.1	0	.	n	.	0	A197.	DEL	197	197	A	644	644	A	182	A	180	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4576	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3016	150.8	1	SNP	p	D86N	0	.	.	256	258	GAC	602	604	GAC	175;173;174	G;A;C	169;168;170	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4576	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3016	150.8	1	SNP	p	S87R	0	.	.	259	261	AGT	605	607	AGT	172;174;174	A,G,C;G;T	165,1,1;170;164	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4576	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3016	150.8	1	SNP	p	S87I	0	.	.	259	261	AGT	605	607	AGT	172;174;174	A,G,C;G;T	165,1,1;170;164	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4576	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3016	150.8	1	SNP	p	S87W	0	.	.	259	261	AGT	605	607	AGT	172;174;174	A,G,C;G;T	165,1,1;170;164	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4576	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3016	150.8	1	SNP	p	S88P	0	.	.	262	264	TCC	608	610	TCC	171;172;176	T;C;C	168;167;172	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4012	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2609	152.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1545	1547	GGC	204;201;197	G;G;C	199;195;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3612	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2241	159.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1199	1201	GCA	197;197;194	G;C,A;A	192;191,1;191	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3612	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2241	159.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1202	1204	ATC	191;192;195	A;T;C	188;189;191	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3612	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2241	159.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1214	1216	GTG	206;204;205	G;T;G	199;198;199	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3612	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2241	159.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1214	1216	GTG	206;204;205	G;T;G	199;198;199	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3612	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2241	159.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1718	1720	ACC	172;174;173	A;C;C	168;171;169	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3612	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2241	159.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1772	1774	GCG	152;155;155	G;C,G;G	145;140,1;145	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3612	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2241	159.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1772	1774	GCG	152;155;155	G;C,G;G	145;140,1;145	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3612	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2241	159.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1895	1897	GGC	132;130;131	G;G;C,A	129;126;126,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3612	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2241	159.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1904	1906	GGC	123;117;115	G;G;C,T	118;112;111,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3612	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2241	159.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1922	1924	CCG	77;77;79	C;C;G	75;74;72	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5206	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3123	165.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2224	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1833	119.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	527	527	C	143	C	130	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2504	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1436	172.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	360	362	GAA	195;195;196	G,A;A;A	191,1;193;192	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2504	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1436	172.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	771	773	TCA	211;215;214	T;C;A	205;208;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2504	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1436	172.3	0	.	p	.	0	E210K	NONSYN	628	630	GAA	876	878	AAA	198;200;202	A;A;A	196;197;197	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2504	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1436	172.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	900	902	GTC	188;188;190	G;T;C	181;177;189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2504	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1436	172.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	912	914	TCT	191;192;194	T;C;T	188;190;192	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2504	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1436	172.3	1	SNP	p	G120K	1	.	.	358	360	AAG	606	608	AAG	209;208;209	A;A;G	203;204;205	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2504	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1436	172.3	1	SNP	p	D121N	0	.	.	361	363	GAC	609	611	GAC	212;208;207	G,A;A;C	207,1;203;204	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2504	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1436	172.3	1	SNP	p	A121D	1	.	.	361	363	GAC	609	611	GAC	212;208;207	G,A;A;C	207,1;203;204	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9256	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4810	191.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1982	1984	AAT	193;192;193	A;A;T	190;188;188	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1110	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1033	106.0	1	SNP	p	V57M	1	.	.	169	171	ATG	522	524	ATG	210;208;205	A,T;T;G	205,1;203;200	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
